Guardian Pharmacy Services, Inc. (NYSE:GRDN) Receives $32.00 Average PT from Analysts

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) have been given a consensus recommendation of “Moderate Buy” by the five brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $32.00.

A number of equities research analysts have recently weighed in on GRDN shares. Oppenheimer started coverage on Guardian Pharmacy Services in a research note on Friday, October 10th. They set an “outperform” rating and a $30.00 price target on the stock. Stephens boosted their target price on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 14th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Guardian Pharmacy Services in a report on Monday, December 29th. Wall Street Zen upgraded shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research note on Monday, November 17th. Finally, Truist Financial upped their target price on Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a research report on Friday, November 14th.

Guardian Pharmacy Services Trading Up 4.7%

Shares of GRDN stock opened at $28.30 on Wednesday. Guardian Pharmacy Services has a 12-month low of $17.78 and a 12-month high of $37.43. The business’s fifty day simple moving average is $29.84 and its 200-day simple moving average is $26.60. The company has a market cap of $1.79 billion, a PE ratio of 44.92 and a beta of 0.96.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Monday, November 10th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.01. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%.The firm had revenue of $377.43 million during the quarter, compared to analysts’ expectations of $381.16 million. On average, equities analysts forecast that Guardian Pharmacy Services will post 0.87 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Guardian Pharmacy Services during the first quarter worth about $233,000. KLP Kapitalforvaltning AS acquired a new stake in Guardian Pharmacy Services during the 2nd quarter valued at approximately $75,000. Allspring Global Investments Holdings LLC lifted its stake in Guardian Pharmacy Services by 0.5% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 285,885 shares of the company’s stock valued at $6,092,000 after acquiring an additional 1,338 shares during the period. Stephens Inc. AR purchased a new stake in shares of Guardian Pharmacy Services in the 2nd quarter valued at $776,000. Finally, Kornitzer Capital Management Inc. KS acquired a new stake in shares of Guardian Pharmacy Services in the second quarter worth $1,066,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.